Determination of Whether Apex or Non-Apex Prostate Cancer Is the Best Candidate for the Use of Prostate-Specific Antigen Density to Predict Pathological Grade Group Upgrading and Upstaging after Radical Prostatectomy.

Huang, Cong; He, Shiming; He, Qun; Gong, Yanqing; Song, Gang; Zhou, Liqun

Huang, Cong; He, Shiming; He, Qun; Gong, Yanqing; Song, Gang; Zhou, Liqun.

Afiliação

Huang C; Department of Urology, Peking University First Hospital, Beijing 100034, China.
He S; Institute of Urology, Peking University, National Urological Cancer Center of China, Beijing 100034, China.
He Q; Department of Urology, Peking University First Hospital, Beijing 100034, China.
Gong Y; Institute of Urology, Peking University, National Urological Cancer Center of China, Beijing 100034, China.
Song G; Department of Urology, Peking University First Hospital, Beijing 100034, China.
Zhou L; Institute of Urology, Peking University, National Urological Cancer Center of China, Beijing 100034, China.

J Clin Med ; 12(4)2023 Feb 19.

Article em En | MEDLINE | ID: mdl-36836195

Palavras-chave

Gleason grade group; apex tumor; prostate cancer; prostate-specific antigen density; upgrading; upstaging

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tipos_de_cancer / Prostata Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Revista: J Clin Med Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google